🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
313,52 USD
Máx. histórico
322,75
4 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-2,86%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,12%
Cierre anterior
307,02
Rango de hoy
309,46 – 317,76
Volumen hoy
195.564
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 33,04 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 22 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 30/01/1996 | 49,59 | 49,59 | 47,26 | 48,66 | -1,89% | 4,72% | 62.116 |
| 29/01/1996 | 48,66 | 50,53 | 47,26 | 49,59 | +3,92% | 6,73% | 74.032 |
| 26/01/1996 | 48,19 | 49,13 | 46,79 | 47,72 | -0,97% | 4,85% | 47.956 |
| 25/01/1996 | 48,19 | 48,19 | 46,79 | 48,19 | +0,98% | 2,91% | 49.266 |
| 24/01/1996 | 47,72 | 48,19 | 45,85 | 47,72 | +0,99% | 4,90% | 57.922 |
| 23/01/1996 | 47,26 | 47,72 | 45,38 | 47,26 | +0,00% | 4,95% | 74.700 |
| 22/01/1996 | 48,19 | 49,59 | 44,92 | 47,26 | -4,72% | 9,71% | 131.606 |
| 19/01/1996 | 46,79 | 50,53 | 44,92 | 49,59 | +3,92% | 12,00% | 125.408 |
| 18/01/1996 | 46,79 | 48,66 | 45,85 | 47,72 | +3,03% | 6,00% | 149.827 |
| 17/01/1996 | 42,58 | 46,32 | 42,11 | 46,32 | +10,00% | 9,89% | 276.037 |
| 16/01/1996 | 42,11 | 42,58 | 40,70 | 42,11 | +0,00% | 4,44% | 63.479 |
| 15/01/1996 | 40,70 | 42,11 | 40,70 | 42,11 | +1,12% | 3,45% | 38.525 |
| 12/01/1996 | 41,17 | 42,11 | 40,24 | 41,64 | +1,14% | 4,55% | 72.990 |
| 11/01/1996 | 37,43 | 41,17 | 37,43 | 41,17 | +7,32% | 10,00% | 51.189 |
| 10/01/1996 | 42,11 | 42,11 | 36,49 | 38,37 | -7,87% | 13,33% | 83.783 |
| 09/01/1996 | 43,51 | 43,98 | 40,70 | 41,64 | -3,26% | 7,53% | 192.654 |
| 08/01/1996 | 42,11 | 46,79 | 41,64 | 43,04 | +2,22% | 12,22% | 125.381 |
| 05/01/1996 | 41,64 | 42,11 | 40,24 | 42,11 | +2,27% | 4,49% | 70.719 |
| 04/01/1996 | 41,17 | 42,11 | 39,30 | 41,17 | +1,15% | 6,82% | 120.546 |
| 03/01/1996 | 38,37 | 41,17 | 38,37 | 40,70 | +4,82% | 7,32% | 62.731 |
| 02/01/1996 | 40,24 | 41,17 | 38,37 | 38,83 | -3,49% | 6,98% | 41.491 |
| 29/12/1995 | 41,64 | 41,64 | 39,77 | 40,24 | -1,15% | 4,49% | 60.433 |
| 28/12/1995 | 42,11 | 42,58 | 40,70 | 40,70 | -1,14% | 4,44% | 95.940 |
| 27/12/1995 | 41,17 | 42,11 | 39,30 | 41,17 | +2,33% | 6,82% | 111.141 |
| 26/12/1995 | 38,37 | 41,17 | 37,43 | 40,24 | +4,88% | 9,76% | 204.035 |
| 22/12/1995 | 35,56 | 39,30 | 35,09 | 38,37 | +7,89% | 11,84% | 243.068 |
| 21/12/1995 | 32,28 | 35,56 | 31,35 | 35,56 | +10,14% | 13,04% | 277.773 |
| 20/12/1995 | 31,35 | 32,28 | 30,88 | 32,28 | +2,98% | 4,48% | 64.761 |
| 19/12/1995 | 30,88 | 31,35 | 30,41 | 31,35 | +1,52% | 3,03% | 24.392 |
| 18/12/1995 | 30,41 | 31,35 | 30,41 | 30,88 | +0,00% | 3,08% | 18.755 |